Hrt Financial LP Sage Therapeutics, Inc. Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 172,051 shares of SAGE stock, worth $942,839. This represents 0.01% of its overall portfolio holdings.

Number of Shares

172,051

Previous 119,332 44.18%

Holding current value

$942,839

Previous $1.3 Million 4.25%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$7.02 - $13.08 $370,087 - $689,564	52,719 Added 44.18%	172,051 $1.24 Million
Q2 2024 Aug 12, 2024	BUY	$10.58 - $17.9 $1.26 Million - $2.14 Million	119,332 New	119,332 $1.3 Million
Q4 2023 Feb 09, 2024	BUY	$17.1 - $22.26 $1.13 Million - $1.47 Million	66,244 New	66,244 $1.44 Million
Q2 2023 Aug 11, 2023	SELL	$40.65 - $59.54 $820,317 - $1.2 Million	-20,180 Reduced 54.43%	16,892 $794,000
Q1 2023 May 12, 2023	BUY	$37.27 - $46.57 $615,774 - $769,429	16,522 Added 80.4%	37,072 $1.56 Million
Q4 2022 Feb 10, 2023	BUY	$32.2 - $43.61 $221,697 - $300,254	6,885 Added 50.38%	20,550 $783,000
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $441,106 - $591,284	13,665 New	13,665 $535,000
Q2 2022 Aug 12, 2022	SELL	$27.52 - $37.99 $531,658 - $733,928	-19,319 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$30.71 - $45.71 $161,381 - $240,206	-5,255 Reduced 21.38%	19,319 $639,000
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $28,610 - $36,368	-772 Reduced 3.05%	24,574 $1.05 Million
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $1.02 Million - $1.45 Million	25,346 New	25,346 $1.12 Million
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $583,923 - $843,645	-10,640 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $211,102 - $289,118	2,988 Added 39.05%	10,640 $796,000
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $1.23 Million - $1.88 Million	-21,113 Reduced 73.4%	7,652 $661,000
Q3 2020 Nov 13, 2020	BUY	$41.13 - $62.45 $545,466 - $828,211	13,262 Added 85.54%	28,765 $1.76 Million
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $402,302 - $668,954	15,503 New	15,503 $644,000
Q4 2019 Feb 14, 2020	SELL	$60.18 - $154.77 $134,081 - $344,827	-2,228 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$140.29 - $189.96 $136,361 - $184,641	-972 Reduced 30.38%	2,228 $312,000
Q2 2018 Aug 15, 2018	BUY	$140.36 - $175.76 $449,152 - $562,432	3,200 New	3,200 $500,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account